The increasing health-care cost of lung cancer treatment has caused debates regarding the reimbursement of new medications. The purpose of this study was to estimate patients' willingness to pay (WTP) for a hypothetical new drug. Methods: Patients with lung cancer were recruited through referrals by senior specialists from two medical centers in Taiwan. Double-bounded dichotomous choice questions and follow-up open-ended questions were employed to elicit patients' WTP. The contingent valuation question assumed that a novel medication was available, which provided a cure for lung cancer; however, patients would have to pay for this new cure out of their own pocket. In addition, the question was asked as to how much patients would be willing to pay for supplementary hospitalization insurance? Interval regression and linear regression were used to estimate the maximum WTP.
Background
Lung cancer is a major cause of cancer mortality the world over [1, 2] . Since 1982, lung cancer has been the second leading cause of cancer mortality for males and the leading cause of cancer mortality for females in Taiwan [3, 4] . Between 1979 and 2002, age-standardized lung cancer mortality rates per 100,000 per year in Taiwan have increased sharply, from 16.13 to 38.38 among men, and from 6.41 to 19 .63 among women [5] . In addition, the female to male ratio of lung cancer patients was higher than the average global ratio, and the cause remains unclear [6] . Worldwide, over one million people die of lung cancer each year. In the United States, lung cancer is the most common cause of cancer deaths in both sexes [7, 8] , and mortality rates in women have risen 500% since 1950 [9] . In the European Union countries, although age-standardized mortality rates have decreased for most cancer sites, lung cancer mortality rates have risen significantly in women [10] .
The prognosis of lung cancer is poor, and according to the reports from Western countries, the overall 5-year survival rate is only 12% to 15% [2] . The high proportion of disseminated disease and poor prognoses in these patients has justified the continued efforts at developing new therapy options. Given the rising rates of cancer prevalence, the influence of treatment guidelines and quality-of-care initiatives, and the increasing focus on treatment reimbursement by the National Health Insurance (NHI), it has become more important than ever to elucidate the costs associated with disease progression to better understand the value of extending progression-free survival time.
Taiwan's national health insurance (NHI) program is a government-run mandatory single payer system, and was implemented in 1995. By 2005, more than 99% of Taiwan's population was covered by the program. The NHI program provides comprehensive coverage, low copayment, freedom to choose any provider, including inpatient care, ambulatory care, laboratory tests, prescription drugs and certain nonprescription drugs, dental services, traditional Chinese medicine, day care for persons with mental illness, home care, and certain preventive services. Bed capacity is distributed evenly across ownership types, 35% in public hospitals, 35% not-for-profit (NFP), and 30% for-profit (FP).
A copayment is required for ambulatory care, inpatient care, and pharmaceuticals. Nevertheless, services for catastrophic diseases, child delivery, and preventive health care, as well as medical services offered in specific mountain areas or on offshore islands, for low-income households, and for veterans, are exempt from the copayment. "Catastrophic diseases" include cancer, chronic mental illness, end-stage renal disease, and congenital illness. For inpatient care, NHI only covers a three-bed hospital room, and patients must pay the difference if they wish to upgrade to a two-bed hospital room or a single-bed hospital room.
The contingent valuation method (CVM) was developed as a method of eliciting WTP. The CVM was originally a method for measuring the benefits of pure public goods and services without markets, such as environmental goods. The theory of this methodology is based on welfare economics, which can quantify the economic value of health-care services from the consumer's point of view [11, 12] . According to welfare economics, the benefit to an individual of a service or an intervention is defined as that individual's maximum willingness to pay (WTP) for the service or intervention. Over the past few decades, a considerable number of health-care studies have been conducted using the CVM, and the validity and reliability of the CVM has been confirmed repeatedly.
The dichotomous choice format involves a binary question to a given price, and has been advocated by the NOAA panel protocol on the CVM [13] . This elicitation method can be statistically highly inefficient in that vastly larger numbers of observations are required to identify the underlying distribution of resource values with any given degree of accuracy. In an effort to extract more information from the respondents, Carson et al. [14] proposed a dichotomous choice with "follow-up question." Here, respondents are provided with an immediate follow-up question with either raised or lowered bids depending on the response to the initial bids. Hanemann et al. [15] used maximum-likelihood models to analyze dichotomous choice with follow-up data, and showed that offering follow-up questions can increase the statistical efficiency in an estimation.
A variant of this method is the double-bounded format, in which two successive binary questions are put to the subject, with a second price conditioned on the responses to the first price. If the respondent answers "yes" to the first question, then the dollar amount is doubled, and the question is asked again. If the respondent then answers "no," then we are able to abound WTP between the dollar amounts. If the respondent initially answers "no," then the dollar amount might be halved and the question is asked again. Respondents end up in four groups: "yes, yes," "yes, no," "no, yes," and "no, no." The benefit of the follow-up question is that analysis of these data substantially reduces the variance of the average willingness to pay estimate. The double-bounded dichotomous choice CV model is more efficient and provides more improved statistical information than the single bounded model [15] [16] [17] .
The purpose of this study was to use the contingent valuation method to elicit the willingness of lung cancer patients to pay for medication that provides a cure and to elucidate the factors affecting WTP. The payment vehicle of this study was an extra monthly premium to be able to receive the new technology medication. A double-bound dichotomous choice method was used to estimate the monetary value a patient placed on a novel medication.
Materials and Methods

Patient Recruitment and Study Design
Patients with a diagnosis of lung cancer and aged 18 or older were recruited. All patients were referred to us when they visited their physicians from the chest department at the Taipei Veterans General Hospital or the Kaohsiung Veterans General Hospital between February 2003 and July of 2004. The physicians explained the study purpose to their patients before referring them to the interviewers. If the patients were not willing to take part in the study, the physician would respect their decisions. Patients who were unaware of their own medical condition were excluded from participating. This study was approved by the IRB board of both medical centers. Written informed consent was obtained from all participants prior to conducting a face-to-face interview.
Patients were interviewed in a secluded interview room by a trained research nurse after their routine consultation. The assessment was carried out using a battery of questionnaires, including sociodemographics, WTP questions, and EQ-5D. The EQ-5D, a five-dimensional (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) health status measure designed by the EuroQol group, is a generic, preference-based health-related quality of life (HRQoL) questionnaire. EQ-5D questionnaire has been widely validated and used to measure cancer patients' health-related quality of life [18] . During the interview, the research nurse, one at each study site, read the questionnaires to the patients and recorded their answers. These research nurses also assessed the patients using the Karnofsky Performance Scale (KPS), and patient clinical information was obtained from their attending doctors.
The KPS [19] was used to assess the patients' ability to carry out activities of daily living. It is rated on a scale of 0-100, in steps of 10, with higher scores representing a better functional status. The KPS has good predictive validity [20] , satisfactory interrater reliability, and sufficient construct and predictive validity [21] .
Questionnaires
As in many other CV studies, this study included three kinds of questions: the CV questions, the respondent's socio demographic variables, and validity checking questions. The bid vector was selected by accounting for the results of the pretest survey. A pretest pilot survey was conducted to revise any misinterpretation of the questions and to identify the bid vector that should be used in the final study. Extra monthly premium was used as the payment method. The method of elicitation used in this study was a double-bound question backed by an open-ended question. It took on average 20-30 minutes to complete the interview. The CV questions started with a scenario description that described the deficit of Taiwan's National Health Insurance. The scenario was described as follows.
The health insurance system in Taiwan is governed by the Bureau of National Health Insurance (BNHI). It provides comprehensive health-care services for all of Taiwan's citizens, with a low registration fee and copayment, as well as a monthly premium. Nevertheless, the BNHI is facing financial difficulties and is in danger of failure. Therefore, the BNHI is planning to strictly control the usage of expensive new medications and its coverage, which means that you have to pay for these medications with your own money.
Assume a novel medication would be available now, that could free of your lung cancer and let you regain your health again without side effects, but the BNHI will not pay for it. Under such circumstance, in addition to your regular monthly premium, would you be willing to pay an additional monthly fee of NTD . . . (each respondent will be encountered an amount of either NTD 500, NTD 700, NTD 1000, NTD 1500, NTD 2000, NTD 2000, NTD 3000, NTD 4000, NTD 5000, NTD 6000, NTD 7000, NTD 8000, or NTD 10,000) (1US$ = NTD 33 during the study period) to receive this new treatment for the rest of your life?
If a respondent indicates a WTP the first amount offered, then a follow-up question with the new threshold at double the first one is asked. If the respondent is unwilling to pay the first amount offered, then the second threshold is reduced to about half the original amount. The respondent only needs to answer "yes" or "no" to these two questions. The interviewer also asks the respondent to consider the situation that if they pay for the new medication they may be short of money for other
expenses. An open-ended question follows the double-bounded dichotomous question: What is the maximum price you would be willing to pay per month for the remedy? NTD_______(open).
The second WTP question is: If the government provides a voluntary additional insurance of 1-year cover for hospitalization, in which any expenses not covered by the current national health insurance are fully paid until discharge. Are you willing to pay an additional NTD_______(one of 2000, 3000, 4000, 5000, 6000, 7000, 8000, 10,000) per year for the premium for this additional insurance?
If the answer is yes, then the question is asked again with the premium doubling; otherwise, it is halved. An open-ended question then follows the double-bounded dichotomous question: How much is the maximum you are willing to pay for the premium per year? NTD_______(open).
Statistical Methods
The patients' WTP for a new cure is assumed to be a function of their socioeconomic and health status variables. The independent variables for predicting the WTP includes sex, marital status, religion, education, employment status, and monthly disposable income. According to the economic theory, income is the single most important factor that will influence patients' WTP. The EQ-5D was used to measure the patients' health-related quality of life. It is assumed that the worse the patient's health status; the more that patient would like to pay to be free of their illness. It is also assumed that patients who live together with family would like to pay for relieving the family caregiver from his/her physical and spiritual burden. Nursing assistants and dietary supplements were used to serve as proxies of patient's ability to pay.
Interval regression and multiple linear regression methods were used to estimate the mean WTP and to explore the influence of independent variables on the referendum data. The independent variables were selected based on the economic theory and relevant knowledge including the WTP, sex, age, marital status, education, religion, job status, health status, income, family care, nursing assistant, dietary supplement and smoke. The elicitation approach is illustrated in the following figure. The study estimated the mean WTP using maximum likelihood methods based on the "intreg" procedure with a robust error estimation by STATA 8.1 (StataCorp, College Station, TX, 2003).
The double-bounded model generated interval censored data on WTP, which was analyzed using survival analysis. The present study used the interval censoring concept to measure patients' WTP for the new hypothetical medication. The possible answers to the double-bound dichotomous choice questions were classified into four patterns p yy , p yn , p ny , and p nn : "YES" to both the first and second question (YY); p yn "YES" to the first question, and "NO" to the second, higher value (YN); p ny "NO" to the first value, and "YES" to the second, lower value (NY); and p nn "NO" to both the first and second value (NN).
Results
Demographic Characteristics
The demographic characteristics and health status of respondents were showed in Table 1 . In total, 294 patients completed the interview. There were more males respondents than female respondents (74.1% vs. 25.9%). Most of the respondents were either married or had partners (83.0%). Most respondents were religious; 52.0% were Buddhist or Taoist, and 10.5% were Christians. More than half the respondents had an education level lower than junior high school, and only 20% of the respondents had a college education. About 80% of the respondents were currently unemployed. Half of the respondents (55.9%) had a monthly disposable income less than NTD 20,000; 33.9% had a monthly income between NTD 20,000 and NTD 49,999; 2.4% had a monthly income of more than NTD 100,000. The mean age of the respondents was 66.5 years old, and the mean number of their immediate family members was 3.8. Their health status measured by the EQ-5D was 0.697 in terms of EQ-5D index and 65.92 in terms of EQ-5D value. Their mean score of KPS was 81.1. Table 2 shows the willingness of lung cancer patients to pay an extra monthly premium t obtain new or experimental medication, if it would return their health. The bids ranged from NTD 500 to NTD 10,000 per month. Each patient was sequentially offered one bid (ranging between NTD 500 and NTD 10,000 per month). As to the lowest bid of NTD 500, 88.5% of the respondents were willing to pay that price. The percentage of WTP went down as the bid values increased. Nevertheless, at the highest bid of NTD 10,000, there were still 23.1% of the respondents that were willing to pay this extra monthly premium. Figure 1 shows the demand curve of the WTP for new medication. 
Single-Bound WTP
Double-Bound WTP
After the first bid, the respondent was offered a second bid which value depended on the answer to the first bid. If the respondent answered "yes" to the first bid, then the second offered bid was doubled, otherwise the second bid price was halved. Our results showed that the percentages of those who would like to pay for both bids decreased if the bid values increased ( Table 3 ). The percentage of patients who answered "yes" for the two lower bids was 72.0%, and it was 4.0% for those who both answered "no." The percentage of patients who answered "yes" for the two higher bids was 15.4%, and it was 53.9% for those who answered "no" to both. The results also showed that the percentage of respondents who gave the same answer for both bids (yes, yes or no, no) was more than 70%, except for NTD 1500 and NTD 6000 as the first bids. For the first bid of NTD 1500, the percentage of the same answer was 60%, and for the first bid of NTD 6000, the percentage of the same answer was only 47.1%. This shows that patients find it difficult to make a decision in this price range. The open question result was analyzed by multiple log-linear regressions. The F test of the multiple repression was significant (P < 0.0005). In this linear regression model, except religion, other significant factors are the same as the previous interval regression. The estimated mean WTP was NTD 7032 (Ϯ5356), which is also similar to the result by interval regression. Table 5 shows the interval regression of the WTP for supplementary hospitalization insurance. The logarithm of monthly household income is a highly significant positive factor. Health status as measured by the KPS also showed a negative influence on patients' WTP. In other words, the healthier the patients were, the less they wanted to pay for a new treatment. The maximum WTP estimated by interval regression was NTD 3089 (Ϯ4962).
Regression Analyses
Discussion
Since 1999, lung cancer has replaced liver cancer as the leading cause of cancer death in Taiwan [22] . The management of lung cancer has changed significantly over the last 10 years. New diagnostic tools and medications have emerged, and these have led to changes in the existing medical treatment paradigm [23] . The continuously increasing health-care cost of lung cancer in developed countries is a reason for serious concern regarding the economics of treatment and disease management [24, 25] . In Taiwan, the policy of BNHI's new drug reimbursement has resulted in BNHI being in debt. Nevertheless, few studies have investigated this issue. Our study provides preliminary results on patients' WTP for their lung cancer treatment.
Our results showed that on average, patients would like to pay patients would like to pay more for the new medication. Family support is an important factor for the patients to cope with the disease. This is especially true in the Chinese culture.
In this study, we assumed that the double-bounded questionnaire provided a larger variety of information, which included the censor data, and thus provided a more precise estimation. We chose the double-bounded questionnaire design and used the interval regression to estimate the mean value of a patient's WTP in reference to Hannemann [15] and Alberini [26] , who found that the double-bounded dichotomous choice CV model is statistically more efficient and is a preferable method to the single bid dichotomous model specifications.
Our results show that a patient's maximum WTP for an effective new medicine is much lower than the cost of current new medications, such as Tarcevas at NTD3000 per pill, costing NTD60,000 to 90,000 per month. The National Health Insurance in Taiwan currently only reimburses Tarcevas as a third-line medication. For those who would like to use it as a first-line medication, they will have to pay for it out of their own pocket. Hence, few patients can afford it. Hideo [27] suggested that government should enforce a safety net for the low-income group to reduce their financial burden. The health-care expenditure is currently around 6.0% of the GDP [28] in Taiwan. Unless it increases premiums or the copayment, NHI will be unable to pay for all the effective new treatments. It is suggested that a prompt economic evaluation of the lifetime cost and effectiveness of any new medication is needed for Taiwan's policymakers.
Reliability and Validity
To enhance the validity of a CV study, Mitchell and Carson [29] stressed that the key scenario elements must be understandable, meaningful, and plausible. That is, the WTP questions must be clear and unambiguous, respondents should be familiar with the commodity to be valued, and respondents should have had prior valuation and choice experience with respect to consumption levels of the commodity. Prior to finalizing the questionnaire, we conducted pilot studies to modify the bid values and contents of the questionnaire to make sure that the language and content were reasonable and easily understood. In addition, our respondents were lung cancer patients, and thus they were well informed regarding the value of the commodity in question. Construct validity should be tested in WTP studies. One logic of construct validation is to determine the theoretical construct [30] . In the regression analysis, theoretic validity can be gauged by regressing the WTP amount on a set of theoretical relevant predictor variables. The size and sign of the estimated coefficients are then examined to determine theoretical consistency. Our results showed that income is a significant positive factor that influences a patient's WTP, which is consistent with the economic theory [30] . Nevertheless, our estimation may be underestimated. It is possible that the WTP value seen in a hypothetical situation is lower than the WTP in a real situation. General criticisms of CVM include the fact that WTP differs from the actual payment [12, 31] , and that the WTP is not a monetary value but only a sense of satisfaction (so-called warm glow) when paying [32] . Another risk is the so-called "strategic bias" [12] . This refers to the tendency of individuals in a survey avoiding giving any responses that may be detrimental to them. As nationwide compulsory health insurance is completely accepted in Taiwan, those citizens who believe that the cost of medical services should be the total responsibility of the government may therefore be psychologically resistant to expensive medical copayment, and this may have reduced the WTP.
Limitation
In this study, all the patients were referred by their physicians. The physicians explained the study purpose to the patient and then referred that patient to the interviewers immediately after that patient's routine consultation. For catastrophic disease, patients were more loyal to their doctors. Hence, the refusal rate was very low (<10%); we did not conduct analyses for those who were not included in the study. A sample size estimation was also not conducted before we started the data collection. Nevertheless, as a total of 294 patients completed the interview; the sample size is larger than the estimated size of a = 0.05 and power = 0.8. The physicians recruited patients sequentially and only excluded those whose diagnoses were as yet not confirmed. Because the respondents that were interviewed were from two major medical centers located in the north and south of Taiwan, respectively, and they were interviewed during a specific period of time, the results of our study may not be generalizable to the entire population of Taiwan. Regarding the reliability, to the best of our knowledge, only two studies, Bryan et al. [33] and Skjoldborg et al. [34] , investigated the reliability over time for a contingent valuation study. Both studies show a high level of reliability. In our study, we conducted a pilot study; however, the reliability was not tested. Hanemann et al. [15] demonstrated that the double-bound approach leads to more efficient welfare measures because it requests more information from the respondent. Nevertheless, a disadvantage of this approach is that the responses to the follow-up questions may lead to WTP estimates that differ from the WTP estimates from the first valuation question [17] In other words, double-bound questions may be prone to a form of starting point bias.
Conclusion
In Taiwan, lung cancer has great impact on both the value of productivity and life lost because of both its incidence and mortality rate. The increasing health-care cost of lung cancer treatment has resulted in many debates on the issue of new drug reimbursement in Taiwan's National Health Insurance. Our study shows that patients would like to pay less than the actual cost of these new medications. Government and health policymakers should consider the ability to pay when making their decision to cover or not to cover new medications.
